Concepedia

Nagashree Seetharamu

NS

Statistics

Publications

17

Citations

795

H-Index

13

Active since

2004

Affiliations

Northwell Health(Current)

Donald & Barbara Zucker School of Medicine at Hofstra/Northwell

St. John's University

Feinstein Institute for Medical Research

New York University

Nagashree Seetharamu is an author at Northwell Health specializing in medicine, oncology, and pharmacology.

ORCID

Publications per year

2004–2024

17

Publications

17

Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine

Ravi Raju Tatapudi, Thangamani Muthukumar, Darshana M. Dadhania et al. · Kidney International · 2004 · 182 citations

, , +14

Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, <i>EGFR</i> –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer

James Chih‐Hsin Yang, Dae Ho Lee, Jong‐Seok Lee et al. · Journal of Clinical Oncology · 2024 · 142 citations · Full text

, , +14

Phase II study of liposomal cisplatin (SPI-77) in platinum-sensitive recurrences of ovarian cancer.

Nagashree Seetharamu, E. Kim, Howard S. Höchster et al. · PubMed · 2010 · 107 citations

, , +16

SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer

Hossein Borghaei, Filippo de Marinis, Daphne W. Dumoulin et al. · Annals of Oncology · 2023 · 93 citations · Full text

, , +13

A randomized, phase 2 trial of docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer

Antonio Jimeno, Julie E. Bauman, Charles Weissman et al. · Oral Oncology · 2015 · 78 citations · Full text

, , +11

1–5 of 17